Suppr超能文献

急性髓系白血病患者的肺部放射学表现及其与化疗和预后的关系:一项单中心回顾性研究。

Pulmonary radiological findings in patients with acute myeloid leukemia and their relationship to chemotherapy and prognosis: a single-center retrospective study.

机构信息

İstanbul University, Cerrahpaşa School of Medicine, Department of Pneumophysiology, Division of Internal Medicine, İstanbul, Turkey.

İstanbul Training and Research Hospital, Department of Hematology, İstanbul, Turkey.

出版信息

Turk J Haematol. 2012 Sep;29(3):217-22. doi: 10.5152/tjh.2011.77. Epub 2012 Sep 15.

Abstract

OBJECTIVE

Acute myeloid leukemia (AML) is the most common acute leukemia in adults. Pulmonary are among the most common causes of mortality in AML. This single-center retrospective study aimed to evaluate the relationship between radiological findings of pulmonary at presentation and post chemotherapy on prognosis and clinical outcome in a group of AML patients.

MATERIAL AND METHODS

The study included 278 AML patients. Clinical and radiological findings, laboratory findings, and microbiological culture results were evaluated. Pulmonary complications at presentation and post chemotherapy were compared.

RESULTS

Pulmonary complications were observed in 53 of the patients (19%). Mean age of the patients with and without pulmonary complications was 43.1 ± 15.2 years and 38.8 ± 16.3 years, respectively (P < 0.001). Pulmonary complications were not correlated with gender, AML subtype, or the serum lactate dehydrogenase (LDH) level. The most common cause of pulmonary complications was infection. Pulmonary complications were observed in 29% and 71% of the patients at presentation and post chemotherapy, respectively.

CONCLUSION

Pulmonary complications were observed more frequently at presentation in neutropenic AML patients of advanced age. The mortality rate was higher among the AML patients that had pulmonary complications at presentation.

摘要

目的

急性髓系白血病(AML)是成人中最常见的急性白血病。肺部感染是 AML 患者死亡的最常见原因之一。本单中心回顾性研究旨在评估 AML 患者肺部表现的影像学特征与化疗后预后和临床结局之间的关系。

材料与方法

研究纳入 278 例 AML 患者。评估了临床和影像学表现、实验室检查和微生物培养结果。比较了患者在就诊时和化疗后出现的肺部并发症。

结果

53 例(19%)患者出现肺部并发症。有肺部并发症和无肺部并发症患者的平均年龄分别为 43.1 ± 15.2 岁和 38.8 ± 16.3 岁(P < 0.001)。肺部并发症与性别、AML 亚型或血清乳酸脱氢酶(LDH)水平无关。肺部并发症最常见的原因是感染。在就诊时和化疗后,分别有 29%和 71%的患者出现肺部并发症。

结论

肺部并发症在高龄中性粒细胞减少性 AML 患者就诊时更为常见。在就诊时即有肺部并发症的 AML 患者死亡率更高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/735a/3986745/2cd6acb4078e/TJH-29-217-g3.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验